Isoniazid preventive therapy: Retrospect and prospect.

Suppr

超能文献

作者信息

Dash L A, Comstock G W, Flynn J P

出版信息

Am Rev Respir Dis. 1980 Jun;121(6):1039-44. doi: 10.1164/arrd.1980.121.6.1039.

DOI:10.1164/arrd.1980.121.6.1039

PMID:7416591

Abstract

摘要

相似文献

Isoniazid preventive therapy: Retrospect and prospect.

Am Rev Respir Dis. 1980 Jun;121(6):1039-44. doi: 10.1164/arrd.1980.121.6.1039.

Isoniazid prophylaxis and deaths in Baltimore, Maryland 1972.1972年马里兰州巴尔的摩市的异烟肼预防治疗与死亡情况

Bull Int Union Tuberc. 1976;51(1):213-23.

Containment of tuberculosis. Preventive therapy with isoniazid, and contact investigation.结核病的控制。异烟肼预防性治疗及接触者调查。

Chest. 1979 Dec;76(6 Suppl):801-4.

Liver enzyme disturbances during isoniazid chemoprophylaxis in children.

Am Rev Respir Dis. 1974 Nov;110(5):581-4. doi: 10.1164/arrd.1974.110.5.581.

From the Centers for Disease Control and Prevention. Severe isoniazid-associated hepatitis--New York, 1991-1993.来自疾病控制与预防中心。重度异烟肼相关性肝炎——纽约，1991年至1993年。

JAMA. 1993 Aug 18;270(7):809.

Severe isoniazid-associated hepatitis--New York, 1991-1993.

MMWR Morb Mortal Wkly Rep. 1993 Jul 23;42(28):545-7.

Isoniazid-associated hepatitis--serum enzyme determinations and histologic features.异烟肼相关性肝炎——血清酶测定及组织学特征

West J Med. 1975 May;122(5):371-6.

Isoniazid prevention of tuberculosis.异烟肼预防结核病。

Lancet. 1983 Feb 19;1(8321):395-6.

Current changes in the recommendations for INH preventive treatment of tuberculous infection in Alabama.阿拉巴马州关于结核感染异烟肼预防性治疗建议的当前变化。

J Med Assoc State Ala. 1974 Sep;44(3):140-1.

Isoniazid-associated hepatitis.

Bull Int Union Tuberc. 1976;51(1):209-12.

引用本文的文献

Incidence, Clinical Features, Associated Factors and Outcomes of Intensive Phase Antituberculosis Drug Induced Liver Injury Among Patients With Tuberculosis at a Tertiary Care Hospital in Nepal: A Descriptive Cross-Sectional Study.尼泊尔一家三级护理医院中结核病患者强化期抗结核药物性肝损伤的发病率、临床特征、相关因素及结局：一项描述性横断面研究

Health Sci Rep. 2025 Apr 21;8(4):e70686. doi: 10.1002/hsr2.70686. eCollection 2025 Apr.

Magnitude, outcome, and associated factors of anti-tuberculosis drug-induced hepatitis among tuberculosis patients in a tertiary hospital in North Ethiopia: A cross-sectional study.在埃塞俄比亚北部一家三级医院中，结核病患者中抗结核药物性肝炎的严重程度、结局及其相关因素：一项横断面研究。

PLoS One. 2020 Nov 10;15(11):e0241346. doi: 10.1371/journal.pone.0241346. eCollection 2020.

Seventy Years of Tuberculosis Prevention: Efficacy, Effectiveness, Toxicity, Durability, and Duration.七十年结核病防治：疗效、效果、毒性、持久性和持续时间。

Am J Epidemiol. 2019 Dec 31;188(12):2078-2085. doi: 10.1093/aje/kwz172.

Screening and treatment for tuberculosis in a cohort of unaccompanied minor refugees in Berlin, Germany.德国柏林无人陪伴未成年难民队列中的结核病筛查和治疗。

PLoS One. 2019 May 21;14(5):e0216234. doi: 10.1371/journal.pone.0216234. eCollection 2019.

variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis.抗结核药物相关的变异和毒性：系统评价和荟萃分析。

Int J Tuberc Lung Dis. 2019 Mar 1;23(3):293-305. doi: 10.5588/ijtld.18.0324.

CYP genetic variants and toxicity related to anti-tubercular agents: a systematic review and meta-analysis.CYP 基因变异与抗结核药物相关毒性：系统评价和荟萃分析。

Syst Rev. 2018 Nov 20;7(1):204. doi: 10.1186/s13643-018-0861-z.

Recurrent Drug-Induced Hepatitis in Tuberculosis-Comparison of Two Drug Regimens.复发性药物性肝炎在结核病中的研究——两种药物治疗方案的比较

Am J Ther. 2017 Mar/Apr;24(2):e144-e149. doi: 10.1097/MJT.0000000000000218.

Expression Profile of Markers of Apoptosis, Injury and Oxidative Stress in Human Lung Epithelium Cells-A5449 Receiving Chronic Exposure of Potential Anti-Tubercular Drug-trans-Cyclohexane-1, 4-Diamine Derivative-"9u".人肺上皮细胞-A5449长期暴露于潜在抗结核药物反式环己烷-1,4-二胺衍生物-“9u”后凋亡、损伤和氧化应激标志物的表达谱

Toxicol Int. 2014 May;21(2):172-8. doi: 10.4103/0971-6580.139803.

Antituberculosis drug-induced hepatotoxicity in children.儿童抗结核药物性肝毒性

Pediatr Rep. 2011 Jun 16;3(2):e16. doi: 10.4081/pr.2011.e16.

Recent developments in treatment of latent tuberculosis infection.潜伏结核感染治疗的最新进展。

Indian J Med Res. 2011 Mar;133(3):257-66.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验